Attempts at Prevention of Intrauterine Death in Erythroblastosis Fetalis
- 19 December 1963
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 269 (25) , 1344-1349
- https://doi.org/10.1056/nejm196312192692504
Abstract
THE prevention of intrauterine death in erythroblastosis fetalis continues to elude solution though attacks on the problem have been made from a number of directions. Fifteen to 20 per cent of fetuses with erythroblastosis caused by Rh incompatibility die in utero between the gestational ages of seventeen and forty weeks — about half of these die before thirty weeks. Fortunately, stillbirth is rare in the large group of cases of erythroblastosis caused by A and B and other blood-group antigens. Anemia is assumed to be the basic cause of intrauterine death, and it probably should be considered an anemia secondary . . .Keywords
This publication has 8 references indexed in Scilit:
- Specific Inhibition of Anti-D Antibody by Colominic AcidNature, 1961
- Experimental Studies on the Prevention of Rh Haemolytic DiseaseBMJ, 1961
- PRELIMINARY EVIDENCE FOR A “DESENSITATION” PROCEDURE IN ERYTHROBLASTOSIS FETALISPlastic and Reconstructive Surgery, 1961
- Effect of Ribonuclease on Erythrocyte AntigensNature, 1960
- The concept of relative bone marrow failureThe American Journal of Medicine, 1957
- Erythroblastosis FetalisNew England Journal of Medicine, 1954
- EVIDENCE FOR ACTIVELY ACQUIRED TOLERANCE TO Rh ANTIGENSProceedings of the National Academy of Sciences, 1954
- Competition of Antigens in Isoimmunization by Pregnancy.Experimental Biology and Medicine, 1945